Medical Devices: Page 2
-
Dexcom faces proposed class action suit over G7 CGM problems
The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
By Elise Reuter • Oct. 20, 2025 -
AdvaMed calls for series of trade actions in response to Section 232 probe
In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a tariff-free trading bloc with trusted countries among its proposals.
By Susan Kelly • Oct. 20, 2025 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Ōura to pursue FDA clearance of blood pressure feature for smart ring
The company has received approval to validate and define the feature in a study that is scheduled to start this year.
By Nick Paul Taylor • Oct. 20, 2025 -
Boston Scientific to buy Nalu Medical for $533M
Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.
By Susan Kelly • Oct. 17, 2025 -
HistoSonics raises $250M to expand use of noninvasive cancer therapy
The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.
By Nick Paul Taylor • Oct. 17, 2025 -
What J&J’s ortho spinoff means for the industry
Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.
By Elise Reuter • Oct. 16, 2025 -
BD CFO Chris DelOrefice leaving for new job
Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.
By Susan Kelly • Oct. 16, 2025 -
To move or not to move? Manufacturers hesitant to nearshore before USMCA review
While some companies are using regional supply chains or leaning on tariff exemptions by maximizing compliance, others are frozen in place.
By Shefali Kapadia • Oct. 16, 2025 -
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
By Elise Reuter • Oct. 15, 2025 -
Stereotaxis teams with CardioFocus to develop robotic PFA system
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
By Nick Paul Taylor • Oct. 15, 2025 -
5 AI takeaways from AdvaMed’s conference
Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.
By Elise Reuter • Oct. 14, 2025 -
Cybersecurity triggers another recall of J&J’s Impella heart pump controller
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
By Nick Paul Taylor • Oct. 14, 2025 -
Intuitive’s challengers continue to advance
Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.
By Susan Kelly • Oct. 10, 2025 -
Zimmer launches 2 devices from $1.1B orthopedic takeover
After acquiring Paragon 28 earlier this year, Zimmer intends to maintain the foot and ankle specialist’s double-digit growth.
By Nick Paul Taylor • Oct. 10, 2025 -
Intuitive expands AI in Ion; Horizon performs first robotic cataract surgery
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
By Susan Kelly • Oct. 10, 2025 -
FDA’s presence at AdvaMed conference shrinks amid shutdown
Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as a government shutdown continues.
By Elise Reuter • Oct. 9, 2025 -
Medtronic begins study of Hugo robot in gynecology
With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on Intuitive Surgical in the U.S. robotic surgery market.
By Susan Kelly • Oct. 9, 2025 -
Owens & Minor inks $375M deal to sell unit to investment firm
The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that provides products directly to patients.
By Nick Paul Taylor • Oct. 8, 2025 -
AdvaMed CEO: ‘Just give us some certainty’
At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the ongoing government shutdown.
By Elise Reuter • Oct. 8, 2025 -
Convatec plans $1B investment in R&D in the US and UK
Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.
By Nick Paul Taylor • Oct. 7, 2025 -
How 4 medtech CEOs are using AI
At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use the technology internally is challenging.
By Elise Reuter • Oct. 7, 2025 -
Sponsored by Arena
How AI-driven supply chain intelligence is transforming medical device manufacturing
AI-powered supply chain intelligence helps MedTech firms overcome EOL risks and regulatory hurdles.
Oct. 6, 2025 -
Q&A
Hospital for Special Surgery’s Ashis Barad says AI must solve real problems
Barad, chief digital and technology officer at HSS, outlined his approach to evaluating AI tools and how the orthopedic hospital uses the technology.
By Elise Reuter • Oct. 3, 2025 -
Medtronic wins CE mark for Penditure LAA exclusion device
The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.
By Nick Paul Taylor • Oct. 3, 2025 -
CDRH shares regulatory guidance priorities for the coming 12 months
Use of real-world evidence to support regulatory decisions and predetermined change control plans for medical devices are two areas of focus for the agency.
By Nick Paul Taylor • Oct. 2, 2025